8ID7 image
Entry Detail
PDB ID:
8ID7
Keywords:
Title:
Crystal structure of YbiW in complex with 1,5-anhydroglucitol-6-phosphate in Escherichia coli
Biological Source:
PDB Version:
Deposition Date:
2023-02-12
Release Date:
2024-10-02
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.28
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
F 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Probable dehydratase YbiW
Mutations:E114A, E115A, K117A
Chain IDs:A
Chain Length:810
Number of Molecules:1
Biological Source:Escherichia coli str. K-12 substr. MG1655
Ligand Molecules
Primary Citation
A Widespread Radical-Mediated Glycolysis Pathway.
J.Am.Chem.Soc. 146 26187 26197 (2024)
PMID: 39283600 DOI: 10.1021/jacs.4c07718

Abstact

Glycyl radical enzymes (GREs) catalyze mechanistically diverse radical-mediated reactions, playing important roles in the metabolism of anaerobic bacteria. The model bacterium Escherichia coli MG1655 contains two GREs of unknown function, YbiW and PflD, which are widespread among human intestinal bacteria. Here, we report that YbiW and PflD catalyze ring-opening C-O cleavage of 1,5-anhydroglucitol-6-phosphate (AG6P) and 1,5-anhydromannitol-6-phosphate (AM6P), respectively. The product of both enzymes, 1-deoxy-fructose-6-phosphate (DF6P), is then cleaved by the aldolases FsaA or FsaB to form glyceraldehyde-3-phosphate (G3P) and hydroxyacetone (HA), which are then reduced by the NADH-dependent dehydrogenase GldA to form 1,2-propanediol (1,2-PDO). Crystal structures of YbiW and PflD in complex with their substrates provided insights into the mechanism of radical-mediated C-O cleavage. This "anhydroglycolysis" pathway enables anaerobic growth of E. coli on 1,5-anhydroglucitol (AG) and 1,5-anhydromannitol (AM), and we probe the feasibility of harnessing this pathway for the production of 1,2-PDO, a highly demanded chiral chemical feedstock, from inexpensive starch. Discovery of the anhydroglycolysis pathway expands the known catalytic repertoire of GREs, clarifies the hitherto unknown physiological functions of the well-studied enzymes FsaA, FsaB, and GldA, and demonstrates how enzyme discovery efforts can cast light on prevalent yet overlooked metabolites in the microbiome.

Legend

Protein

Chemical

Disease

Primary Citation of related structures